NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib

Leukemia. 2017 Oct;31(10):2264-2267. doi: 10.1038/leu.2017.235. Epub 2017 Jul 10.

S Sopper^{1

2}, S Mustjoki^{3

4}, B T Gjertsen⁵, F Giles⁶, A Hochhaus⁷, J J W M Janssen⁸, K Porkka³, D Wolf^{1

2

9}

¹ Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria.
² Tyrolean Cancer Research Institute, Innsbruck, Austria.
³ Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
⁴ Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
⁵ Institute of Medicine, Hematology Section, University of Bergen, Bergen, Norway.
⁶ NMDTI, Northwestern University, Chicago, USA.
⁷ Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
⁸ Department of Hematology, VU University Medical Center, Amsterdam, Netherlands.
⁹ Department of Hematology, Oncology, Immunoncology and Rheumatology, Center of Integrated Oncology Cologne Bonn, University Hospital of Bonn, Bonn, Germany.

No abstract available

Publication types